Development of tissue factor-targeted liposomes for effective drug delivery to stroma-rich tumors
- 1 July 2020
- journal article
- research article
- Published by Elsevier in Journal of Controlled Release
- Vol. 323, 519-529
Abstract
No abstract availableKeywords
Funding Information
- National Cancer Center Japan
This publication has 29 references indexed in Scilit:
- TGF-β and the Tissue Microenvironment: Relevance in Fibrosis and CancerInternational Journal of Molecular Sciences, 2018
- The role of stromal cancer-associated fibroblasts in pancreatic cancerJournal of Hematology & Oncology, 2017
- Nanomedicine strategies to overcome the pathophysiological barriers of pancreatic cancerNature Reviews Clinical Oncology, 2016
- Role of TGFβ in regulation of the tumor microenvironment and drug delivery (Review)International Journal of Oncology, 2015
- Liposomal drug delivery systems: From concept to clinical applicationsAdvanced Drug Delivery Reviews, 2013
- The inhibition of pancreatic cancer invasion-metastasis cascade in both cellular signal and blood coagulation cascade of tissue factor by its neutralisation antibodyEuropean Journal of Cancer, 2011
- Incidence of Venous Thromboembolism in Patients Hospitalized with CancerThe American Journal of Medicine, 2006
- Vascular Permeability Factor/Vascular Endothelial Growth Factor: A Critical Cytokine in Tumor Angiogenesis and a Potential Target for Diagnosis and TherapyJournal of Clinical Oncology, 2002
- Involvement of the Kinin‐generating Cascade in Enhanced Vascular Permeability in Tumor TissueJapanese Journal of Cancer Research, 1988
- Tumors: Wounds That Do Not HealNew England Journal of Medicine, 1986